Paracetamol Study in Patients With Low Muscle Mass

Clinical Trial ID NCT03648658

Rank	Title	Journal	Year	PubWeight™‹?›
1	A report: the definition and classification of cerebral palsy April 2006.	Dev Med Child Neurol Suppl	2007	9.30
2	Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial.	JAMA	2006	3.49
3	Kinetics and metabolism of paracetamol and phenacetin.	Br J Clin Pharmacol	1980	1.87
4	Clinical pharmacokinetics of paracetamol.	Clin Pharmacokinet	1982	1.54
5	Acetaminophen hepatotoxicity: An update.	Curr Gastroenterol Rep	2000	1.12
6	Childhood hepatotoxicity with paracetamol doses less than 150 mg/kg per day.	Med J Aust	1999	1.11
7	Skeletal muscle glutathione is depleted in critically ill patients.	Crit Care Med	1997	0.87
8	Spinal Muscular Atrophy.	Neurol Clin	2015	0.86
9	Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies.	Anaesthesia	2008	0.84
10	Acute liver failure after recommended doses of acetaminophen in patients with myopathies.	Crit Care Med	2011	0.83
11	Patients with severe muscle wasting are prone to develop hypoglycemia during fasting.	Neurology	2003	0.81
12	Morbidly Obese Patients Exhibit Increased CYP2E1-Mediated Oxidation of Acetaminophen.	Clin Pharmacokinet	2016	0.78
13	Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.	Eur J Clin Pharmacol	2017	0.75